Research Topics
| G M LiuzziSummaryAffiliation: University of Bari Country: Italy Publications
| Collaborators
|
Detail Information
Publications
Regulation of gelatinases in microglia and astrocyte cell cultures by plant lectinsG M Liuzzi
Dipartimento di Biochimica e Biologia Molecolare, University of Bari, Italy
Glia 27:53-61. 1999....
Interferon-beta inhibits the expression of metalloproteinases in rat glial cell cultures: implications for multiple sclerosis pathogenesis and treatmentGrazia Maria Liuzzi
Department of Biochemistry and Molecular Biology, University of Bari, 70126 Bari, Italy
Mult Scler 10:290-7. 2004..These results demonstrate a modulating effect of IFN-beta on the release of MMPs from CNS cells. This effect represents an additional mechanism by which IFN-beta, may decrease the development of new CNS lesions in the course of MS...
Anti-HIV drugs decrease the expression of matrix metalloproteinases in astrocytes and microgliaG M Liuzzi
Department of Biochemistry and Molecular Biology, University of Bari, Via Orabona 4, 70126 Bari, Italy
Brain 127:398-407. 2004....
Structure-dependent inhibition of gelatinases by dietary antioxidants in rat astrocytes and sera of multiple sclerosis patientsGrazia Maria Liuzzi
Department of Biochemistry and Molecular Biology, Ernesto Quagliariello, University of Bari, Via Orabona 4, 70126, Bari, Italy
Neurochem Res 36:518-27. 2011..Therefore, their combined use may represent a powerful tool for the down-regulation of MMPs in the course of MS...
Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesisG M Liuzzi
Department of Biochemistry and Molecular Biology, University of Bari, Italy
Mult Scler 8:222-8. 2002....
Changes of serum sICAM-1 and MMP-9 induced by rIFNbeta-1b treatment in relapsing-remitting MSM Trojano
Department of Neurological and Psychiatric Sciences, University of Bari, Italy
Neurology 53:1402-8. 1999....
Adhesion molecules and matrix metalloproteinases in Multiple Sclerosis: effects induced by Interferon-betaC Avolio
Neurology Unit, University of Foggia, Foggia, Italy
Brain Res Bull 61:357-64. 2003..This review will highlight the effects induced by rIFNbeta, both in vitro and in vivo, on cell-bound and soluble forms of AMs and on MMPs...
Lipoprotein(a) in the cerebrospinal fluid of neurological patients with blood-cerebrospinal fluid barrier dysfunctionGabriella Pepe
Department of Biochemistry and Molecular Biology, University of Bari, Italy
Clin Chem 52:2043-8. 2006....
Inhibitory effect of polyunsaturated fatty acids on MMP-9 release from microglial cells--implications for complementary multiple sclerosis treatmentGrazia Maria Liuzzi
Department of Biochemistry and Molecular Biology, University of Bari, Bari, Italy
Neurochem Res 32:2184-93. 2007..Our results suggest that a low fat diet supplemented with omega-3 PUFA may become recommended for the well being of MS patients under therapy...
Inhibition of aquaporin-4 expression in astrocytes by RNAi determines alteration in cell morphology, growth, and water transport and induces changes in ischemia-related genesGrazia Paola Nicchia
Department of General and Environmental Physiology and Center of Excellence in Comparative Genomics (CEGBA, University of Bari, I-70126 Bari, Italy
FASEB J 17:1508-10. 2003....
The different forms of PNS myelin P0 protein within and outside lipid raftsAnna Fasano
Dipartimento di Biochimica e Biologia Molecolare Ernesto Quagliariello, University of Bari, Bari, Italy
J Neurochem 107:291-301. 2008..Our findings suggest that structural differences between the two proteins, mainly related to the glycogroups, might be responsible for their different localization...
A monoclonal antibody inhibits gelatinase B/MMP-9 by selective binding to part of the catalytic domain and not to the fibronectin or zinc binding domainsErik Martens
Rega Institute for Medical Research, Laboratory of Immunobiology, University of Leuven, Minderbroedersstraat 10, B 3000 Leuven, Belgium
Biochim Biophys Acta 1770:178-86. 2007..These results define part of the catalytic domain of gelatinase B/MMP-9, and not the zinc-binding or fibronectin domains, as target for the development of selective inhibitors...
Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypesCarlo Avolio
Neurology Unit, University of Foggia, Italy
J Neuroimmunol 136:46-53. 2003..These results show that an increase in MMP-2/TIMP-2 ratio marks chronic progression in MS, but it is as high as in HC, and also confirm that high MMP-9 activity characterizes short duration relapsing and active forms of the disease...
